Metropolitan Life Insurance Company (MetLife)’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-11,135
| Closed | -$45.7K | – | 2473 |
|
|
2022
Q1 | $45.7K | Sell |
11,135
-34,401
| -76% | -$125K | ﹤0.01% | 1649 |
|
|
2021
Q4 | $163K | Buy |
45,536
+3,286
| +8% | +$11.5K | ﹤0.01% | 2160 |
|
|
2021
Q3 | $154K | Buy |
42,250
+6,837
| +19% | +$27.6K | ﹤0.01% | 2272 |
|
|
2021
Q2 | $154K | Sell |
35,413
-10,014
| -22% | -$40.8K | ﹤0.01% | 2337 |
|
|
2021
Q1 | $187K | Sell |
45,427
-1,073
| -2% | -$4.65K | ﹤0.01% | 2068 |
|
|
2020
Q4 | $186K | Sell |
46,500
-1,121
| -2% | -$3.63K | ﹤0.01% | 1982 |
|
|
2020
Q3 | $129K | Sell |
47,621
-6,116
| -11% | -$16.9K | ﹤0.01% | 2076 |
|
|
2020
Q2 | $148K | Buy |
53,737
+398
| +0.7% | +$1.11K | ﹤0.01% | 2017 |
|
|
2020
Q1 | $126K | Buy |
53,339
+705
| +1% | +$2.4K | ﹤0.01% | 1882 |
|
|
2019
Q4 | $247K | Buy |
52,634
+15,889
| +43% | +$65K | ﹤0.01% | 1772 |
|
|
2019
Q3 | $123K | Sell |
36,745
-14,622
| -28% | -$48.1K | ﹤0.01% | 2185 |
|
|
2019
Q2 | $169K | Hold |
51,367
| – | – | ﹤0.01% | 2000 |
|
|
2019
Q1 | $156K | Sell |
51,367
-245
| -0.5% | -$794 | ﹤0.01% | 2065 |
|
|
2018
Q4 | $140K | Hold |
51,612
| – | – | ﹤0.01% | 2053 |
|
|
2018
Q3 | $173K | Hold |
51,612
| – | – | ﹤0.01% | 2099 |
|
|
2018
Q2 | $133K | Buy |
51,612
+28,875
| +127% | +$71.8K | ﹤0.01% | 2177 |
|
|
2018
Q1 | $50K | Sell |
22,737
-22,131
| -49% | -$49.8K | ﹤0.01% | 2440 |
|
|
2017
Q4 | $89K | Sell |
44,868
-58,661
| -57% | -$128K | ﹤0.01% | 2375 |
|
|
2017
Q3 | $335K | Sell |
103,529
-458
| -0.4% | -$1.41K | ﹤0.01% | 1956 |
|
|
2017
Q2 | $335K | Buy |
+103,987
| New | +$295K | ﹤0.01% | 1985 |
|
|
2016
Q1 | – | Sell |
-116,522
| Closed | -$141K | – | 2539 |
|
|
2015
Q4 | $141K | Buy |
116,522
+1,380
| +1% | +$1.92K | ﹤0.01% | 2458 |
|
|
2015
Q3 | $196K | Buy |
115,142
+56,852
| +98% | +$111K | ﹤0.01% | 2296 |
|
|
2015
Q2 | $121K | Sell |
58,290
-41,770
| -42% | -$101K | ﹤0.01% | 2579 |
|
|
2015
Q1 | $271K | Sell |
100,060
-430
| -0.4% | -$1.09K | ﹤0.01% | 1891 |
|
|
2014
Q4 | $258K | Hold |
100,490
| – | – | ﹤0.01% | 2226 |
|
|
2014
Q3 | $184K | Buy |
100,490
+62,465
| +164% | +$136K | ﹤0.01% | 2441 |
|
|
2014
Q2 | $102K | Sell |
38,025
-54,018
| -59% | -$163K | ﹤0.01% | 2687 |
|
|
2014
Q1 | $322K | Hold |
92,043
| – | – | ﹤0.01% | 2114 |
|
|
2013
Q4 | $412K | Buy |
92,043
+2,323
| +3% | +$9.46K | ﹤0.01% | 1939 |
|
|
2013
Q3 | $364K | Sell |
89,720
-2,195
| -2% | -$9.59K | ﹤0.01% | 1974 |
|
|
2013
Q2 | $382K | Buy |
+91,915
| New | +$355K | ﹤0.01% | 1879 |
|
Other funds holding ATRS
Metropolitan Life Insurance Company (MetLife)'s ATRS Position: Q2 2022 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 11,135 shares — an estimated $45.7K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in ATRS in Q2 2013 and held it in 31 quarters. The position peaked at $412K in Q4 2013. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 11,135 Antares Pharma, Inc. shares in Q2 2022, an estimated $45.7K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Antares Pharma, Inc. in Q2 2013 and held it in 31 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Antares Pharma, Inc. position peaked at $412K in Q4 2013.
- 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2022, filed 11 Aug 2022.